Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Ann Neurol. 2012 Jul;72(1):4-5. doi: 10.1002/ana.23655.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Mesenchymal Stem Cell Transplantation / methods*
  • Multiple System Atrophy / therapy*
  • Transplantation, Autologous